Company Snapshot: HGSI  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Human Genome Sciences Announces Webcast of Investment Conference Presentation

   HUMAN GENOME SCIENCES LOGO
Human Genome Sciences, Inc. logo. (PRNewsFoto)[TC]
ROCKVILLE, MD USA
    ROCKVILLE, Md., Jan. 3 /PRNewswire/ -- Human Genome Sciences, Inc.
(Nasdaq: HGSI) announced today that its presentation to the JPMorgan H&Q 20th
Annual Healthcare Conference will be webcast and may be accessed at
http://www.hgsi.com .
    (Photo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )
    Human Genome Sciences' senior management will provide an overview of the
Company on Monday, January 7, 2002, at 5:30 p.m. Eastern Time.  Investors
interested in listening to the live webcast should log on before the
presentation begins in order to download any software required.  The archive
of the presentation will be available for several days beginning two hours
after the presentation.
    Human Genome Sciences is a company with the mission to treat and cure
disease by bringing new gene-based drugs to patients.
    HGS and Human Genome Sciences are registered trademarks of Human Genome
Sciences, Inc.  For additional information on Human Genome Sciences, Inc.,
visit the company's web site at http://www.hgsi.com .  Copies of HGSI press
releases are also available by fax 24 hours a day at no charge by calling
800-758-5804, ext. 121115.



SOURCE Human Genome Sciences, Inc.




Back to Topback to top

Related links:
  • http://www.hgsi.com
    Company News On-Call:
  • http://www.prnewswire.com/comp/121115.html
  • http://www.prnewswire.com/comp/637873.html
    Photo Notes:http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO
    AP Archive: http://photoarchive.ap.org
    PRN Photo Desk, 888-776-6555 or 212-782-2840
    CONTACT:
    Jerry Parrott (media), or Kate de Santis
    (investors), of Human Genome Sciences, +1-301-309-8504